CD8A and cancer: Kaplan Meier analysis showed that patients with low pretransplant proportions of CD4+CD45RChigh (Fig 1C) or CD8+CD45RChigh T cells (Fig 1D) had a significantly lower survival without cancer as compared to patients with high proportions.